Hyperemesis gravidarum: severe pregnancy sickness, impaired intake, assessment, supportive care and uncertain treatment comparisons

Severity, intake and consequences are different measurements

Recognition should include what a person can manage

The Windsor definition was developed through international multistakeholder consensus to improve consistency in identifying hyperemesis. It centres severe symptoms, impaired normal intake and marked effects on daily living, with early onset. It is a clinical definition, not a test showing that all vomiting in pregnancy has the same cause. Dehydration can support the assessment but its absence does not exclude the illness. Research using older definitions may therefore enrol different populations, affecting comparisons between studies.[1]

Reduced intake and dehydration warrant prompt help

NHS guidance advises contacting a midwife or doctor when frequent vomiting prevents keeping food or drink down. Dehydration can involve thirst, tiredness, dizziness and dark, strong-smelling urine. Do not dismiss persistent inability to drink as a normal inconvenience of pregnancy. Clinical care can assess the person and provide treatment; severe uncontrolled symptoms may require hospital care. This is guidance for seeking assessment, not a home diagnosis or a substitute for emergency care when someone is acutely unwell.[2]

A urine ketone result should not decide whether illness is serious

The RCOG clinical guideline recommends validated symptom tools such as PUQE and HELP to describe severity. It explicitly states that ketonuria is not an indicator of dehydration and should not be used to assess severity. Functional impairment, intake and clinical findings remain relevant. A person should not have to demonstrate a particular urine result to have severe symptoms taken seriously. Assessment also needs to consider other causes of vomiting rather than attributing every new symptom to pregnancy.[3]

Published questions

Care addresses hydration, nutrition and medication tolerability

RCOG describes clinician-selected antiemetic treatment, monitored intravenous hydration and electrolyte assessment when needed. Severe intake reduction also requires attention to thiamine and nutritional support. Treatment choices weigh effectiveness, previous adverse reactions, pregnancy-specific evidence and risks of inadequately controlled illness. These are care components, not a personal drug sequence, infusion formula or supplement schedule; the appropriate combination depends on an individual assessment.[3]

A lack of clear superiority differs from absence of useful care

The 2016 Cochrane review included 25 trials involving 2,052 women across 18 comparisons of medicines, fluids, outpatient care and other approaches. Most comparisons relied on small single studies, with mixed methods and low or very low certainty for many outcomes. There was little evidence establishing one intervention as consistently superior. That conclusion concerns comparative research available to that dated review. It does not show that treatment is unnecessary or that all interventions are equally effective, equally safe or interchangeable.[4]

Routine early tube feeding did not improve the trial’s main outcome

The 2017 MOTHER trial randomized 116 women hospitalized with hyperemesis to early enteral tube feeding plus standard care or standard care alone. Birthweight and several maternal and neonatal secondary outcomes did not clearly improve. Only 47% allocated to tube feeding received it according to protocol, and discomfort contributed to discontinuation. This questions routine early use of that protocol; it does not establish that nutritional support is never appropriate in severe or refractory illness. The method, tolerance and clinical context matter.[5]

Pregnancy-outcome associations are uncertain and do not predict an individual result

Moberg and colleagues’ 2023 review included 23 studies, with searches through September 2021. It found associations between hyperemesis and preterm birth, small-for-gestational-age birth and low birthweight, but rated the evidence very uncertain. Definitions, severity and study design differed, and most evidence was observational. Confounding and selection can influence the findings. Ordinary nausea and hyperemesis were not treated as interchangeable exposures. These results support appropriate monitoring while avoiding the claim that a sick person will inevitably have an adverse outcome or caused one through inadequate intake.[6]

Psychological distress deserves care without being labelled the cause

A review published online in 2016 and in a 2017 journal issue included 59 articles, with 12 studies pooled. Depression and anxiety scale scores were higher among women with hyperemesis than controls without significant pregnancy sickness. Variation between studies was substantial, and symptom scales do not establish a psychiatric diagnosis or the direction of causation. Physical symptoms can disrupt daily life, relationships and access to support. The findings support listening and appropriate psychological care alongside physical treatment; they do not establish that distress caused the vomiting.[7]

A biological pathway is not yet a personal treatment instruction

Fejzo and colleagues’ Nature study, published online in December 2023, investigated GDF15, a hormone acting on the brainstem. Human blood measurements and genetic evidence implicated fetal–placental production and maternal sensitivity; experiments in mice examined the influence of prior exposure. The authors proposed a causal contribution to pregnancy nausea and hyperemesis and possible future treatment approaches. These mixed human and experimental findings do not validate a routine GDF15 test, prove one person’s cause or establish a safe intervention to alter hormone exposure during pregnancy.[8]

References

1. The Windsor definition for hyperemesis gravidarum: a multistakeholder international consensus definition

   International consensus definition

   Jansen and colleagues · Content/publication date: 2021
   Accessed: 2026-10-14 UTC · Original indexed abstract or selected indexed original passages inspected on 2026-10-14 UTC; direct opening was attempted but returned an incomplete page, challenge or access error; full text not independently appraised
   Cited sections: 2021-09-10; Online publication; mandatory features, early onset and contributory dehydration

   Original abstract also inspected in bounded delegated retrieval turn1758view0; subsequent direct opening exposed only an incomplete page.

2. Severe vomiting in pregnancy

   Agency condition or prevention explanation

   NHS · Content/publication date: 2023
   Accessed: 2026-10-14 UTC · Selected relevant original official or professional guidance passages inspected on 2026-10-14 UTC; no independent clinical appraisal
   Cited sections: 2023-01-11; Last reviewed date; impaired intake, dehydration signs, illness impact and support

   Page review due date is January 2026; actual last-reviewed date retained. Not presented as newly published evidence.

3. The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69)

   Clinical guideline

   Nelson-Piercy and colleagues / RCOG · Content/publication date: 2024
   Accessed: 2026-10-14 UTC · Selected relevant original official or professional guidance passages inspected on 2026-10-14 UTC; no independent clinical appraisal
   Cited sections: 2024-02-04; Original publisher key recommendations: PUQE/HELP, ketonuria, antiemetic and monitored supportive-care principles

   Original key recommendations inspected, not complete appendices. Both linked corrections were inspected: 19 June 2025 (turn1832view0, DOI18258: saline terminology and prochlorperazine route) and 30 June 2026 (turn1832view1, DOI70298: infusion-time correction). No dose, route-specific regimen or infusion schedule was authored.

4. Interventions for treating severe nausea and vomiting during pregnancy (hyperemesis gravidarum)

   Systematic review

   Boelig and colleagues / Cochrane · Content/publication date: 2016
   Accessed: 2026-10-14 UTC · Original abstract and bibliographic record inspected on 2026-10-14 UTC; full study or review not independently appraised
   Cited sections: 2016-05-12; Original review summary/abstract; 25 trials, 18 comparisons and comparative uncertainty

5. Early enteral tube feeding in optimizing treatment of hyperemesis gravidarum: MOTHER randomized controlled trial

   Randomized controlled trial

   Grooten and colleagues · Content/publication date: 2017
   Accessed: 2026-10-14 UTC · Original publisher indexed abstract inspected on 2026-10-14 UTC; original PubMed record also inspected but later direct requests were incomplete; full paper not independently appraised
   Cited sections: 2017-08-09; Online date verified in original PubMed record turn1846search3; September issue; original publisher abstract, 116 randomized women and poor tolerability

   No numeric birthweight confidence interval reproduced: the abstract’s printed interval differs from arithmetic expectation, and the qualitative conclusion is sufficient. Migrated publisher page issue label says March 2017; original bibliographic record says September 2017, which is retained.

6. Placenta-associated adverse pregnancy outcomes in women experiencing mild or severe hyperemesis gravidarum: a systematic review and meta-analysis

   Systematic review

   Moberg and colleagues · Content/publication date: 2023
   Accessed: 2026-10-14 UTC · Original full-text definition, methods, results and discussion passages inspected on 2026-10-14 UTC; no independent systematic appraisal
   Cited sections: 2023-05-24; Original abstract and methods/results; 23 studies, September 2021 search and very uncertain evidence

7. Psychological morbidity associated with hyperemesis gravidarum: a systematic review and meta-analysis

   Systematic review

   Mitchell-Jones and colleagues · Content/publication date: 2016
   Accessed: 2026-10-14 UTC · Original abstract and bibliographic record inspected on 2026-10-14 UTC; full study or review not independently appraised
   Cited sections: 2016-07-14; Online publication; January 2017 issue; original abstract, scales and substantial heterogeneity

   Later critique of symptom measurement was observed in linked records; no symptom-scale association was framed as a diagnosis or psychological cause.

8. GDF15 linked to maternal risk of nausea and vomiting during pregnancy

   Original mechanistic research

   Fejzo and colleagues · Content/publication date: 2023
   Accessed: 2026-10-14 UTC · Original indexed abstract or selected indexed original passages inspected on 2026-10-14 UTC; direct opening was attempted but returned an incomplete page, challenge or access error; full text not independently appraised
   Cited sections: 2023-12-13; Online publication; January 2024 Nature issue; original author-repository abstract, human genetic/biochemical and mouse experiments

   Original Nature URL opening failed at publisher authorization redirect. The original author-repository abstract was actually retrieved; a proposed target was not portrayed as an approved pregnancy treatment.

Scope & review

Population

Pregnant people with severe nausea/vomiting and impaired intake; trial hospitalization and gestational eligibility retained

Exposure or intervention

Hyperemesis definitions, clinical severity assessment, supportive care, treatment comparisons and mechanism research

Comparison

Ordinary pregnancy nausea distinguished from hyperemesis; source-specific standard care, trial interventions and observational controls

Outcomes

Function, hydration/nutrition, symptoms, pregnancy outcomes, tolerability and psychological support

Timeframe

Windsor onset before 16 weeks; source-specific acute treatment and pregnancy outcomes; early onset does not imply symptoms always stop at 16 weeks

Jurisdiction

UK NHS/RCOG clinical education and original international consensus, trials, reviews and mixed human/animal mechanistic evidence; access and care plans vary locally

Selected-source educational explanation. Official guidance, original study findings and editorial interpretation are distinguished. No exhaustive search, independent systematic synthesis or qualified medical review has been completed.

Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.

What this article still leaves open

• Which contemporary definitions best support recognition without delaying care?
• Which interventions are more effective and tolerable for defined severity groups?
• How can studies distinguish effects of illness, treatment, nutrition and confounding on later outcomes?

Related reading

Explore the topic map

Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.